Matches in Wikidata for { <http://www.wikidata.org/entity/Q37277165> ?p ?o ?g. }
- Q37277165 description "article científic" @default.
- Q37277165 description "article scientifique" @default.
- Q37277165 description "articolo scientifico" @default.
- Q37277165 description "artigo científico" @default.
- Q37277165 description "artículu científicu espublizáu en 2009" @default.
- Q37277165 description "bilimsel makale" @default.
- Q37277165 description "bài báo khoa học" @default.
- Q37277165 description "scientific article published on 16 June 2009" @default.
- Q37277165 description "vedecký článok" @default.
- Q37277165 description "vetenskaplig artikel" @default.
- Q37277165 description "videnskabelig artikel" @default.
- Q37277165 description "vědecký článek" @default.
- Q37277165 description "wetenschappelijk artikel" @default.
- Q37277165 description "wissenschaftlicher Artikel" @default.
- Q37277165 description "наукова стаття, опублікована в червні 2009" @default.
- Q37277165 description "научни чланак" @default.
- Q37277165 description "مقالة علمية نشرت في 16 يونيو 2009" @default.
- Q37277165 name "Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy" @default.
- Q37277165 name "Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy" @default.
- Q37277165 name "Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy." @default.
- Q37277165 type Item @default.
- Q37277165 label "Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy" @default.
- Q37277165 label "Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy" @default.
- Q37277165 label "Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy." @default.
- Q37277165 prefLabel "Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy" @default.
- Q37277165 prefLabel "Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy" @default.
- Q37277165 prefLabel "Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy." @default.
- Q37277165 P1433 Q37277165-170DEEBA-B79D-4C5C-858C-5407EC97087E @default.
- Q37277165 P1476 Q37277165-F407CBC2-844C-4E63-9032-3ACD87C4E1B9 @default.
- Q37277165 P2093 Q37277165-1B5DF5E6-3B1C-4AB0-836D-93080D1E608A @default.
- Q37277165 P2093 Q37277165-8138F9EB-23E6-471A-9E2E-2BE3A77A4B5D @default.
- Q37277165 P2093 Q37277165-957E0E18-DF03-433B-A8B2-B7B09D297CA1 @default.
- Q37277165 P2093 Q37277165-A5F7BA00-F8CA-4FD6-90BD-2738AADFFA93 @default.
- Q37277165 P2093 Q37277165-BD522937-D883-4F21-91F1-4CEBE57BF9D5 @default.
- Q37277165 P2093 Q37277165-C407ACF2-5C77-441C-812E-B3295059EB86 @default.
- Q37277165 P2093 Q37277165-CC31A1B9-54AB-4095-B692-F8F94DE165BB @default.
- Q37277165 P2093 Q37277165-D98D97E0-17D1-4177-954A-E0751E722280 @default.
- Q37277165 P2093 Q37277165-E30B010C-E500-44B4-A595-962E76272A4B @default.
- Q37277165 P2093 Q37277165-E3732254-CCB1-409B-8AAA-97B302BC1A23 @default.
- Q37277165 P2093 Q37277165-F943EA90-B9D7-4912-A243-D5CEFFAE749D @default.
- Q37277165 P2860 Q37277165-05CE6F54-1535-4462-8539-AF142FAF714A @default.
- Q37277165 P2860 Q37277165-07A76DC7-2239-43BF-819F-72720F18219D @default.
- Q37277165 P2860 Q37277165-0C1A37E0-7DD8-4010-BEC7-5D3760C1E42E @default.
- Q37277165 P2860 Q37277165-157AF18A-C8A0-4BC7-B8AC-A42F4ACECA43 @default.
- Q37277165 P2860 Q37277165-162F9266-7AEE-4202-B020-373AF832AA50 @default.
- Q37277165 P2860 Q37277165-27790B6C-4908-4D50-B3FA-6DB6651B152D @default.
- Q37277165 P2860 Q37277165-32C2DB78-91B6-4EB7-9281-2E0593D227BC @default.
- Q37277165 P2860 Q37277165-35C8EAB9-D776-4685-8FC4-6BED0943A433 @default.
- Q37277165 P2860 Q37277165-3841796F-B442-4967-9195-372516E39645 @default.
- Q37277165 P2860 Q37277165-408D8D55-2114-46F3-8F81-94596B8AD8D8 @default.
- Q37277165 P2860 Q37277165-4F4D7706-DAD9-438A-8071-35F99B1F5912 @default.
- Q37277165 P2860 Q37277165-4FC5AE97-CE38-45AE-BD03-9A98D40071DE @default.
- Q37277165 P2860 Q37277165-5851E331-09C4-4311-A857-CDE348BA5D7C @default.
- Q37277165 P2860 Q37277165-6497FBD8-DEAC-4338-9B7A-A34F5A7CE099 @default.
- Q37277165 P2860 Q37277165-6C87B856-9E8B-4C6A-9247-D9166A616277 @default.
- Q37277165 P2860 Q37277165-71D12747-3F05-4029-A51B-64E03C35B689 @default.
- Q37277165 P2860 Q37277165-7BBF8B67-70A9-49BD-A0E3-F31E4E9BCF0A @default.
- Q37277165 P2860 Q37277165-809F76BD-E524-4D60-83C5-758E5DACE982 @default.
- Q37277165 P2860 Q37277165-83F17CCD-B838-4FA4-938F-27A201BA817D @default.
- Q37277165 P2860 Q37277165-8738F71A-DBFE-471D-A77C-340B7FBE63E2 @default.
- Q37277165 P2860 Q37277165-8AE69E73-2B71-4E7B-9E9D-F22845640D5E @default.
- Q37277165 P2860 Q37277165-9181FCE7-EF18-4DE7-9807-78ACD2462A3B @default.
- Q37277165 P2860 Q37277165-A0734D69-0881-45A5-9672-E0C259829BB6 @default.
- Q37277165 P2860 Q37277165-AD86336C-60FF-4AD9-AAAE-50B494BA2F15 @default.
- Q37277165 P2860 Q37277165-ADB38975-46D1-4142-9C65-45FC2462D21F @default.
- Q37277165 P2860 Q37277165-B336B689-3242-430E-9991-5B2087DD9837 @default.
- Q37277165 P2860 Q37277165-B426A94C-141A-43E2-90B6-8C15CB53435E @default.
- Q37277165 P2860 Q37277165-B7352875-4B98-44D3-A1B6-818B16D82FC6 @default.
- Q37277165 P2860 Q37277165-BB81CA78-9550-4D10-84A0-2B0169501806 @default.
- Q37277165 P2860 Q37277165-C0FE1ED2-A0F5-4F32-AB09-77D53CE7BE62 @default.
- Q37277165 P2860 Q37277165-C36F652A-D852-4564-B4FF-451E45F20601 @default.
- Q37277165 P2860 Q37277165-CE62A005-BF6A-48EC-A251-2DA7F95D476F @default.
- Q37277165 P2860 Q37277165-D0F30370-A39C-4D9D-B65B-F4216D60306D @default.
- Q37277165 P2860 Q37277165-DC2D29B1-1108-4A34-9D30-7498AA7C1FF3 @default.
- Q37277165 P2860 Q37277165-DDE63525-93A5-46BC-86B4-FF3EBB28F06E @default.
- Q37277165 P2860 Q37277165-E1AE7E96-982B-49CB-A613-D629B4AEBA1A @default.
- Q37277165 P2860 Q37277165-E8261E4F-A458-4588-800B-1DFCC1E8612D @default.
- Q37277165 P2860 Q37277165-EED12780-97BF-4F46-98CF-6171772B65D6 @default.
- Q37277165 P2860 Q37277165-F4417ADC-8476-4B92-8FAF-09EE27BE7DFC @default.
- Q37277165 P2860 Q37277165-F6F38B04-2D71-4D02-8EBB-9E2BDDCF9A29 @default.
- Q37277165 P2860 Q37277165-FAEAFD6C-ED66-4423-B896-4A7DEC365364 @default.
- Q37277165 P2888 Q37277165-7EE98B0B-15B7-43BF-BB43-74EF97F9813B @default.
- Q37277165 P304 Q37277165-D4538EEE-5B33-4E30-9856-3A1FD689A88D @default.
- Q37277165 P31 Q37277165-98BB98A0-EC2F-4C95-91F0-D6F209DCD1DA @default.
- Q37277165 P356 Q37277165-19A78937-61E0-4755-9DC9-0D142F4555D2 @default.
- Q37277165 P433 Q37277165-76220189-388C-4C36-8707-EF67DD7CA6B6 @default.
- Q37277165 P478 Q37277165-1F20C212-A726-469E-9D0D-4120CE794AA6 @default.
- Q37277165 P577 Q37277165-036BAFC9-B856-4CFB-9A5E-D0E8C3B51927 @default.
- Q37277165 P5875 Q37277165-A42CA600-00E3-4538-8A82-7913D60D13E1 @default.
- Q37277165 P6179 Q37277165-B2CED5A2-F63A-4C82-BD89-F5DE44756E36 @default.
- Q37277165 P698 Q37277165-08C6D930-D734-464D-B12C-26AD6ECAD812 @default.
- Q37277165 P932 Q37277165-78380C83-3D27-4945-8962-3303D289FFF8 @default.
- Q37277165 P356 BCR2320 @default.
- Q37277165 P698 19531217 @default.
- Q37277165 P1433 Q2208481 @default.
- Q37277165 P1476 "Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy" @default.
- Q37277165 P2093 "Basileios Venizelos" @default.
- Q37277165 P2093 "Christos Markopoulos" @default.
- Q37277165 P2093 "Dimitrios Koukouras" @default.
- Q37277165 P2093 "Evagelos Tzoracoleftherakis" @default.